Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–12 of 12 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05705492
- Conditions
- Advanced Biliary Tract Carcinoma, Advanced Esophageal Carcinoma, Advanced Lung Carcinoma, +30 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT07405086
- Conditions
- Adenocarcinoma, Advanced Biliary Tract Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +63 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT07036380
- Conditions
- Advanced Biliary Tract Carcinoma
- Locations
-
- CHU de Besançon Besançon, France
- Centre georges-François Leclerc Dijon, France
- CHU de Grenoble Grenoble, France
- Centre Léon Bérard Lyon, France
Recruiting
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT05969860
- Conditions
- Advanced Anal Carcinoma, Advanced Appendix Carcinoma, Advanced Basal Cell Carcinoma, +57 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Altru Cancer Center Grand Forks, North Dakota, United States
Recruiting
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
NCT07392541
- Conditions
- Advanced Biliary Tract Carcinoma
- Locations
-
- Tongji Hospital Wuhan, Hubei, China
NCT05733000
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT03092895
- Conditions
- Advanced Biliary Tract Carcinoma, Advanced Primary Liver Cancer
- Locations
-
- The Second Affiliated Hospital Of Anhui Medical University Hefei, Anhui, China
- Hunan Cancer Hospital Hunan, Changsha, China
- Cancer Hospital of Henan province Zhengzhou, Henan, China
- 81 Hospital Nanjing Nanjing, Jiangsu, China
Completed
Pembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma
NCT04550624
- Conditions
- Advanced Biliary Tract Carcinoma
- Locations
-
- Shanghai Jiahui International Hospital Shanghai, Shanghai Municipality, China
- Shanghai Zhongshan Hospital Shanghai, Shanghai Municipality, China
NCT01828034
- Conditions
- Advanced Biliary Tract Carcinoma
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)
NCT05564403
- Conditions
- Adenocarcinoma, Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma, +28 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
Active, Not Recruiting
Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer
NCT05451290
- Conditions
- Advanced Biliary Tract Carcinoma
- Locations
-
- the First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Active, Not Recruiting
Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy.
NCT03704480
- Conditions
- Advanced Biliary Tract Carcinoma
- Locations
-
- CHRU Jean Minjoz Besançon, France
- Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
- Hôpital Duchenne Boulogne-sur-Mer, France
- CHU Morvan Brest, France